Ronald J Wainz, MD | |
2109 Hughes Dr, Ste 760, Toledo, OH 43606-5111 | |
(419) 291-7555 | |
(419) 479-2696 |
Full Name | Ronald J Wainz |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 40 Years |
Location | 2109 Hughes Dr, Toledo, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447256839 | NPI | - | NPPES |
0742692 | Medicaid | OH | |
PARAMOUNT | Other | OH | 00713 |
000000135801 | Other | OH | ANTHEM |
290D610410 | Other | MI | BLUE CROSS OF MI |
4648159 | Medicaid | MI | |
4365000 | Medicaid | MI | |
711246 | Other | OH | BUCKEYE COMM HEALTH |
2648697 | Medicaid | MI | |
026011200 | Other | OH | FEDERAL BALCK LUNG |
026011200 | Other | OH | ENERGY EMPLOYESS OCCUP IL |
107274 | Other | MI | GREAT LAKES HEALTH PLAN |
34164561200 | Other | OH | BUR OF WORKERS COMP |
4080258 | Other | OH | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 58375 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Promedica Toledo Hospital | Toledo, OH | Hospital |
Fostoria Community Hospital | Fostoria, OH | Hospital |
Memorial Hospital | Fremont, OH | Hospital |
Bay Park Community Hospital | Oregon, OH | Hospital |
Emma L Bixby Medical Center | Adrian, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Promedica Central Physicians | 2365348190 | 818 |
Promedica Central Physicians | 2365348190 | 818 |
News Archive
Dozens of counties in the Midwest and South are at the highest risk for opioid deaths in the United States, say University of Michigan researchers.
Three Austrian men have become the first in the world to undergo a new technique called "bionic reconstruction", enabling them to use a robotic prosthetic hand controlled by their mind, according to new research published in The Lancet.
Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February 18th in the journal Immunity reveals that the oral pathogen Fusobacterium nucleatum protects a variety of tumor cells from being killed by immune cells.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of gastric cancer, Roche/Genentech/ Chugai's Herceptin as an add-on to standard chemotherapy earns Decision Resources' proprietary clinical gold standard status in 2013, following its approval for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer in 2010.
› Verified 7 days ago
Entity Name | Promedica Central Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
Dozens of counties in the Midwest and South are at the highest risk for opioid deaths in the United States, say University of Michigan researchers.
Three Austrian men have become the first in the world to undergo a new technique called "bionic reconstruction", enabling them to use a robotic prosthetic hand controlled by their mind, according to new research published in The Lancet.
Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February 18th in the journal Immunity reveals that the oral pathogen Fusobacterium nucleatum protects a variety of tumor cells from being killed by immune cells.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of gastric cancer, Roche/Genentech/ Chugai's Herceptin as an add-on to standard chemotherapy earns Decision Resources' proprietary clinical gold standard status in 2013, following its approval for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer in 2010.
› Verified 7 days ago
Entity Name | Promedica Central Physicians, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245444959 PECOS PAC ID: 6709975345 Enrollment ID: O20071204000485 |
News Archive
Dozens of counties in the Midwest and South are at the highest risk for opioid deaths in the United States, say University of Michigan researchers.
Three Austrian men have become the first in the world to undergo a new technique called "bionic reconstruction", enabling them to use a robotic prosthetic hand controlled by their mind, according to new research published in The Lancet.
Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February 18th in the journal Immunity reveals that the oral pathogen Fusobacterium nucleatum protects a variety of tumor cells from being killed by immune cells.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of gastric cancer, Roche/Genentech/ Chugai's Herceptin as an add-on to standard chemotherapy earns Decision Resources' proprietary clinical gold standard status in 2013, following its approval for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer in 2010.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ronald J Wainz, MD 2109 Hughes Dr, Ste 760, Toledo, OH 43606-5111 Ph: (419) 291-7555 | Ronald J Wainz, MD 2109 Hughes Dr, Ste 760, Toledo, OH 43606-5111 Ph: (419) 291-7555 |
News Archive
Dozens of counties in the Midwest and South are at the highest risk for opioid deaths in the United States, say University of Michigan researchers.
Three Austrian men have become the first in the world to undergo a new technique called "bionic reconstruction", enabling them to use a robotic prosthetic hand controlled by their mind, according to new research published in The Lancet.
Bacteria that are commonly found in the mouth are often abundant in patients with colon cancer, but the potential role these microbes play in tumor development has not been clear. A study published by Cell Press February 18th in the journal Immunity reveals that the oral pathogen Fusobacterium nucleatum protects a variety of tumor cells from being killed by immune cells.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of gastric cancer, Roche/Genentech/ Chugai's Herceptin as an add-on to standard chemotherapy earns Decision Resources' proprietary clinical gold standard status in 2013, following its approval for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer in 2010.
› Verified 7 days ago
Dr. Mani Khorsand Askari, M.D, FACP Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3000 Arlington Ave Ofc, Toledo, OH 43614 Phone: 419-383-6821 Fax: 419-383-6180 | |
Hoda Shabpiray, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3125 Transverse Dr, Toledo, OH 43614 Phone: 419-383-3627 Fax: 419-383-2021 | |
Theodore J. Ware, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2409 Cherry St, Suite 207, Toledo, OH 43608 Phone: 419-251-4696 Fax: 419-251-3572 | |
Muhammad Rizwan Faisal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2142 N Cove Blvd, Toledo, OH 43606 Phone: 419-291-1111 | |
Drew Randall Oostra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2109 Hughes Dr Ste 450, Toledo, OH 43606 Phone: 419-291-2003 Fax: 419-479-6977 | |
Dr. Caitlyn Marie Hollingshead, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave # Ms 1201, Toledo, OH 43614 Phone: 419-383-3780 Fax: 419-383-2021 | |
Naeem A Lughmani, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-479-5392 |